Tabula Rasa HealthCare In... (TRHC)
NASDAQ: TRHC
· Real-Time Price · USD
10.50
0.09 (0.86%)
At close: Nov 02, 2023, 9:00 PM
Tabula Rasa HealthCare Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 338.12M | 320.68M | 299.52M | 302.49M | 311.98M | 321.69M | 331.26M | 322.63M | 306.55M | 301.07M |
Cost of Revenue | 258.28M | 247.41M | 232.6M | 230.49M | 231.42M | 232.05M | 233.36M | 228.25M | 216.33M | 210.77M |
Gross Profit | 79.84M | 73.28M | 66.91M | 72M | 80.56M | 89.64M | 97.9M | 94.38M | 90.22M | 90.31M |
Operating Income | -46.78M | -47.84M | -60.44M | -70.71M | -61.8M | -70.48M | -69.32M | -73.61M | -77.56M | -68.94M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -60.82M | -63.74M | -76.94M | -79.81M | -70.89M | -79.31M | -78.43M | -87.31M | -93.75M | -87.62M |
Net Income | -61.18M | -64.02M | -85.14M | -88.14M | -79.37M | -87.76M | -79.06M | -88.31M | -92.79M | -86.02M |
Selling & General & Admin | 88.98M | 85.97M | 85.47M | 93.2M | 85.52M | 94.47M | 99.73M | 95.56M | 93.12M | 88.2M |
Research & Development | 10.33M | 11.8M | 14.48M | 16.12M | 17.09M | 19.77M | 19.79M | 19.32M | 19.44M | 17.34M |
Other Expenses | 18.88M | 23.8M | 17.61M | 11.21M | 5.49M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 123.73M | 121.57M | 123.3M | 138.65M | 138.3M | 156.06M | 167.22M | 162.94M | 160.72M | 152.3M |
Interest Expense | 6.73M | 8.03M | 9.03M | 9.58M | 9.09M | 8.83M | 9.11M | 13.7M | 16.19M | 18.68M |
Selling & Marketing Expenses | 10.86M | 10.29M | 10.49M | 14.86M | 18.22M | 22.37M | 25.97M | 24.74M | 23.55M | 22.25M |
Cost & Expenses | 382.01M | 368.98M | 355.9M | 369.14M | 369.72M | 388.11M | 400.58M | 391.19M | 377.05M | 363.06M |
Income Tax Expense | 252K | 278K | 389K | 529K | 670K | 644K | 627K | 1M | -961K | -1.6M |
Shares Outstanding (Basic) | 25.42M | 25.24M | 24.94M | 24.35M | 23.96M | 23.87M | 23.47M | 23.41M | 23.27M | 23.01M |
Shares Outstanding (Diluted) | 25.42M | 25.24M | 24.94M | 24.35M | 23.96M | 23.87M | 23.47M | 23.41M | 23.27M | 23.01M |
EPS (Basic) | -2.47 | -2.61 | -3.51 | -3.68 | -3.35 | -3.73 | -3.4 | -3.85 | -4.11 | -3.86 |
EPS (Diluted) | -2.47 | -2.61 | -3.51 | -3.68 | -3.35 | -3.73 | -3.4 | -3.85 | -4.11 | -3.86 |
EBITDA | -23.55M | -24.85M | -29.72M | -34.6M | -17.92M | -20.47M | -21.61M | -20.5M | -22.35M | -15.24M |
EBIT | -54.49M | -56.11M | -71.97M | -66.01M | -57.59M | -66.27M | -61.04M | -73.61M | -58.86M | -50.25M |
Depreciation & Amortization | 25.48M | 24.87M | 31.74M | 37.13M | 43.02M | 49.15M | 47.71M | 48.06M | 48.16M | 46.75M |